Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

USCIS Policy Change Impacting Work Authorization: Advisory for Employers and Human Resources

Client Alert

On December 2, 2025, USCIS issued Policy Memorandum PM-602-0192 ordering an immediate pause on processing immigration benefits for individuals whose country of birth or citizenship is one of 19 designated “high-risk” countries. USCIS also mandated a re-review of many previously approved immigration benefits for individuals from these countries who entered the U.S. on or after January 20, 2021.

This memo has direct consequences for employment authorization, reverification, and overall workforce stability.


Who Is Affected?

1. Employees born in or citizens of the following countries may face delays or disruptions in work authorization:

Afghanistan, Burkina Faso, Burundi, Chad, Cuba, Democratic Republic of the Congo, Equatorial Guinea, Eritrea, Haiti, Iran, Laos, Libya, Mali, Nicaragua, North Korea, Somalia, South Sudan, Sudan, Syria, Venezuela, Yemen.

2. Any employee who entered the United States after January 20, 2021 and received work authorization or a green card through the asylum process.


Key Impacts on Employers

1. Delays or Loss of Work Authorization

Employees from affected countries may not be able to renew their Employment Authorization Documents (EADs).
Because USCIS previously reduced automatic extension policies, some employees may lose work authorization immediately upon expiration.

2. Re-Review of Previously Approved Status

Even employees with asylum, permanent residency (green cards), TPS, pending adjustment, or long-standing EADs, and who entered the United States after January 20, 2021 may undergo mandatory re-screening.

USCIS may:

  • Request new interviews
  • Re-open previously approved cases
  • Suspend or revoke status if security concerns are identified

This may occur without advance notice.

3. Mandatory I-9 Compliance

Employers must continue to ensure that every employee maintains valid work authorization.
Failure to re-verify documents or employing an unauthorized worker may result in:

  • Civil fines
  • Criminal penalties for repeat violations
  • Debarment from federal contracts
  • Increased audit exposure during this heightened enforcement period

Recommended HR Actions

  • Review Your Workforce: Identify employees who may be affected based on nationality or birth country. Confirm work authorization expiration dates and update internal tracking systems.
  • Communicate Early: Inform affected employees about the USCIS freeze and encourage them to consult immigration counsel. Advise employees not to travel internationally without legal guidance.
  • Strengthen I-9 Procedures: Ensure reverification systems are updated and reminders are in place. Document all good-faith compliance efforts in case of an audit.
  • Prepare Operational Contingency Plans: Since employees may lose authorization unexpectedly, prepare plans to prevent business disruption, including coverage for key roles.

If you have any questions about how this USCIS policy change may impact your workforce or compliance obligations, please contact BMD Immigration Attorney and Member Rob Ratliff at raratliff@bmdllc.com.


CMS Releases CY 2026 Medicare Physician Fee Schedule Final Rule with Key Payment and Telehealth Updates

CMS issued the CY 2026 Medicare Physician Fee Schedule Final Rule on October 31, 2025, with changes effective January 1, 2026. The Final Rule includes increases to the conversion factor, a new efficiency adjustment, updates to practice expense methodology, permanent telehealth policy changes, revised payment for skin substitutes, expanded rules for Part B drugs and biologicals, enhanced policies for Rural Health Clinics and Federally Qualified Health Centers, and new care management and behavioral health services.

Ohio Department of Medicaid Updates: Key Changes to Physician Reimbursement Rates in Early Parenthood

The Ohio Department of Medicaid has proposed amending Ohio Administrative Code Rule related to covered Medicaid reimbursements for physicians. Beginning on January 1, 2026, they are proposing an increase to rates for prenatal care, childbirth, and infant care and provider visits.

Name, Image, and Likeness Agreements in Healthcare

For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.

Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.

Top Compliance Risks for Ohio Med-Spas in 2025

The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.